Table 3.
Gene Symbol | Gene Name | Fold-Regulation* | P | Function |
---|---|---|---|---|
Alox12 | Arachidonate 12-lipoxygenase | −1.91324 | 0.030 | Signal transduction phospholipase A2 pathway |
Arrb1 | Beta-ARRESTIN 1/negative regulators of GPCR | −1.60338 | 0.012 | Signal transduction G-protein coupled receptor regulation |
Cgn | cingulin | −1.62 | 0.049 | Blood—brain barrier |
Dbh | dopamine β-hydroxylase (DβH) enzyme | −1.7011 | 0.030 | Dopamine metabolism |
Drd1 | Dopamine receptor D1 | −1.75465 | 0.025 | Dopamine receptor |
Drd5 | Dopamine receptor D5 | −1.70713 | 0.032 | Dopamine receptor |
Egr1 | Early growth response 1 | 1.74 | 0.046 | Synaptic plasticity; pain |
Fos | Transcription factor/essential role in stress resilience | −1.61098 | 0.033 | Signal transduction; cAMP & protein kinase A signaling |
Gabrd | GABAA receptor subunit δ | 1.58754 | 0.017 | Neurotransmitter receptor: GABAergic synapse |
Gch1 | GTP cyclohydrolase | 2.94 | 0.016 | Pain; dopamine biosynthesis |
Grik4 | Glutamate receptor, ionotropic, kainite subunit KA1 | 2.91804 | 0.016 | Neurotransmitter receptor glutamatergic synapse |
Grik5 | Glutamate receptor, ionotropic, kainite subunit KA2 | 1.74256 | 0.024 | Neurotransmitter receptor glutamatergic synapse |
Grk6 | G protein-coupled receptor kinase 6 | −1.5332 | 0.033 | Regulation of dopamine receptors |
Gpr84 | G protein-coupled receptor 84 | −3.00 | 0.015 | Pain |
Gpr171 | G protein-coupled receptor 171 | −1.73 | 0.022 | Energy/metabolism |
Il1b | Interleukin-1β | 2.0868 | 0.016 | Immune |
Kmo | Kynurenine-3-monooxygenase | −2.18 | 0.050 | Tryptophan metabolism |
Lin 7B | Lin 7 homolog B | −3.55 | 0.045 | Synaptic plasticity |
Mmp15 | Metalloprotease 15 | −1.83 | 0.049 | Blood—brain barrier |
Nr4a1 | Nuclear receptor Nur77 | −1.58885 | 0.023 | Dopamine & serotonin target |
Pde10a | Phosphodiesterase 10A | −1.51367 | 0.024 | Signal transduction Phospholipase A2 pathway |
Pik3cg | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | −1.52318 | 0.031 | Signal transduction AKT andPI3 kinase signaling |
Plcb1 | Phospholipase C β1 | −1.52803 | 0.031 | Signal transduction phospholipase C signaling |
Rab33a | RAB33A member of Ras oncogene family | −3.67 | 0.018 | Synaptic plasticity |
Rapgef6 | Rap guanine nucleotide exchange factor 6 | −1.61 | 0.019 | Blood—brain barrier |
Rgs20 | Regulator of G protein signaling | −1.65 | 0.029 | Synaptic plasticity |
Slc6a3 | Dopamine transporter (DAT1) | −1.5978 | 0.042 | Dopamine transporter |
Slc6a4 | Solute carrier family 6α member 4/serotonin transporter | −5.76338 | 0.033 | Serotonin transporter |
Synpo | Synptopodin | −2.25 | 0.036 | Synaptic plasticity |
Tbc1d1 | TBC1 family domain member 1 | −1.55 | 0.042 | Energy/metabolism |
Th | Tyrosine hydroxylase/involved in dopamine synthesis | −2.23353 | 0.013 | Dopamine metabolism |
Tjp2 | Tight junction protein 2 | −2.68 | 0.023 | Blood—brain barrier |
Tph2 | tryptophan hydroxylase 2 | −3.77918 | 0.010 | Serotonin metabolism |
Data represent mRNA expression levels relative to the control and expressed as fold-regulation.
AKT = protein kinase B; cAMP = cyclic adenosine monophosphate; dUTPase = deoxyuridine triphosphate nucleotidohydrolase; EBV = Epstein-Barr virus; GABA = γ-aminobutyric acid; GPCR = G protein-coupled receptor; IL = interleukin; PI3 = phosphoinositide 3; TBC1 = TBC1 family domain member 1.
Mean fold-change in expression significantly different from control by ≥ 1.5, n = 3.